To further explore the potential of apoptosis inhibition as a way to sensitize lung cancer for therapy, we tested M867, a novel chemical and reversible caspase-3 inhibitor [18], in combination with ionizing radiation in vivo and in vitro. Here, CASP3 is linked to lung carcinoma.